Advances in cognitive therapy

Current Opinion in Psychiatry

Volumn 10, Issue 3, 1997, Pages 256-260

  Scott, Jan ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE THERAPY; DEPRESSION; HOSPITAL ADMISSION; HUMAN; NEUROSIS; PSYCHOSIS; SHORT SURVEY;

EID: 0030905344     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199705000-00016     Document Type: Short Survey

References (25)

1. Scott J: Cognitive therapy of affective disorders: a review. J Affect Disord 1995, 1:1-11. The author provides a comprehensive review of process and outcome research on the use of cognitive therapy in depressive disorders treated in outpatient and inpatient settings.
2. Sharpe M, Hawton K, Simkin S, Surawy S, Hackmann A, Klimes I, Peto T, Warrell D, Seagroatt V: Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized control trial. BMJ 1996, 312:22-26. A randomized control trial that identifies the longer-term benefits of a cognitive therapy model specifically designed to focus on abnormal illness beliefs and behaviours.
3. Speckens A, van Hermert A, Spinhoven P, Bolk J, Hawton K, Rooijmans G: Cognitive behaviour therapy for medically unexplained physical symptoms: a randomized control trial. BMJ 1995, 311:328-332. A randomized control trial that not only identifies the additional benefits of cognitive therapy in the treatment of somatization disorders but also highlights the health gain that can be achieved simply by optimizing routine medical care.
4. Drury V, Birchwood M, Cochrane R. Macmillan M: Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. Br J Psychiatry 1996, 169:593-601. Despite the overenthusiastic interpretation of the modest results by the authors. this study provides very important evidence of how cognitive therapy may be combined with medication to benefit a group of patients who have not previously been regarded as good candidates for psychotherapy.
5. Kemp R, Hayward P, Applewhaithe G, Everitt B, David A: Compliance therapy in psychotic patients: a randomized controlled trial. BMJ 1996, 312:345-349. A small but pragmatic study that suggests that a brief course of cognitive therapy may improve treatment compliance and, therefore, outcome for acutely ill patients. This work has obvious implications for the interventions made by mental health professionals, particularly community psychiatric nurses and case managers.
6. Emanuels-Zuureen L, Emmelkamp P: Individual behavioural-cognitive therapy vs. marital therapy for depression in maritally distressed couples. Br J Psychiatry 1996, 169:181-188.
7. Warwick H, Clark D, Cobb A, Salkovskis P: A controlled trial of cognitive-behavioural treatment of hypochondriasis. Br J Psychiatry 1996, 169:189-195. An important study that represents the first controlled trials of treatment for hypochondriasis.
8. Dolan M, Bishay N: The effectiveness of cognitive therapy in the treatment of non-psychotic morbid jealousy. Br J Psychiatry 1996, 168: 588-593.
9. Drury V, Birchwood M, Cochrane R, Macmillan M: Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time. Br J Psychiatry 1996, 169:602-607.
10. Fava G, Grandi S, Zielezny, Rafanelli C, Canestrari R: Four-year outcome for cognitive behavioural treatment of residual symptoms in major depression. Am J Psychiatry 1996, 153:945-947. This paper is important for two reasons. It highlights the long-term benefits of cognitive therapy in preventing depressive relapse even after the course of therapy has ended and it reminds clinicians that pharmacotherapy can only prevent relapse if people remain permanently on treatment.
11. Foa E, Hearst-Ikeda D, Perry K: Evaluation of a cognitive-behavioural program for the prevention of chronic PTSD in recent assault victims. J Consult Clin Psychol 1995, 63:948-955.
12. Scott C,Tacchi M, Jones R, Scott J: Is a little enough? A randomised controlled trial of abbreviated cognitive therapy for major depressive disorder in primary care. Br J Psychiatry 1997 (In press).
13. Hardy G, Barkham M, Shapiro D, Rees A, Stiles W, Reynolds S: Impact of Cluster C personality disorders on outcomes of contrasting brief psychotherapies for depression. J Consult Clin Psychol 1995, 63:997-1004.
14. Blouin J, Schnarre K, Carter J, Blouin A, Tener L, Zuro C, Barlow J: Factors affecting dropout rate from cognitive-behavioural group treatment for bulimia nervosa. Int J Eating Disord 1995, 17:323-329.
15. Elkin I, Gibbons R, Shea T, Sotsky S, Watkins J, Pilkonis P, Hedeker D: Initial severity and differential treatment outcome in the NIMH treatment of depression collaborative research programme. J Consult Clin Psychol 1995, 63:841-847
16. Shapiro D, Rees A, Barkham M, Hardy G, Reynolds S, Startup M: Effects of treatment duration and severity of depression on the maintenance of gains after cognitive-behavioural and psychodynamic-interpersonal psychotherapy. J Consult Clin Psychol 1995, 63:378-387 A further analysis of the cohort of patients in the Sheffield psychotherapy project, this paper is particularly valuable because of the thoughtful and well-constructed discussion on patient and therapist variables that influence outcome.
17. Thase M, Dube S, Bowler K, Howland R, Myers J, Friedman E, Jarrett D: Hypothalamic-pituitary adrenocortical activity and response to cognitive behaviour therapy in unmedicated hospitalized depressed patients. Am J Psychiatry 1996, 153:886-891. Thase and his research team distinguish themselves by the quality of their research on the inter-relationship and interaction between biological and cognitive variables in depression.
18. Scott J, House R, Harrington J, Ferner I: A preliminary study of the relationship between personality, cognitive vulnerability, symptom profile and outcome in major depression. J Nerv Mental Dis 1996, 168: 503-505. This small study is interesting as it suggests that in nonpsychotic depression, individuals with biological vulnerability (as measured by hypercortisolaemia) and cognitive vulnerability (as defined by poor problem-solving skills) to depression may be independent. The researchers suggest that this information may be used to determine whether patients may benefit from pharmacotherapy or cognitive therapy.
19. Kingdon D, Tyrer P, Seivewright N, Ferguson B, Murphy S: The Nottingham study of neurotic disorders: influence of cognitive therapists on outcome. Br J Psychiatry 1996, 169:93-97. A study that helps put the rather disappointing performance of cognitive therapy in the earlier outcome studies from this project in context. The study reinforces the need to monitor quality of all treatments, whether psychological or pharmacological in controlled treatment trials.
20. Gaffan E, Tsaousis I, Kemp-Wheeler S: Researcher allegiance and meta analysis: the case of cognitive therapy for depression. J Consult Clin Psychol 1995, 6:966-980. A comprehensive and up-to-date review that confirms the efficacy of cognitive therapy but also explores the reasons for the reduced influence of therapist allegiance in recent studies.
21. Muran J, Gorman B, Safran J, Twining L, Samstag L, Winston A: Linking in-session change to overall outcome in short-term cognitive therapy. J Consult Clin Psychol 1995, 4:651-657. A valuable piece of process research that identifies the effective components of cognitive therapy.
22. •.6] highlighting the need for caution rather than unbridled optimism.
23. Persons J, Thase M, Crits-Christoph P: The role of psychotherapy in depression: review of two practice guidelines. Arch Gen Psychiatry 1996, 53:283-290. A valuable critique of the strengths and weaknesses of guidelines on depression management.
24. Scott J: The role of cognitive behaviour therapy in bipolar disorder. Behav Cogn Psychother 1996, 24:195-208.
25. Brown T, Barlow D: Long-term outcome of cognitive behavioural treatment of panic disorder: clinical predictors and alternative strategies for assessment. J Consult Clin Psychol 1995, 5:754-765. The discussion section of this paper provides a useful review of current research methodologies and offers constructive ideas on how to improve prospective outcome studies.